Naloxone
(asked on 26th February 2026) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will provide an analysis of trends relating to the distribution of take home naloxone kits between 2022 and 2025.
Access to naloxone is vital to respond to the threat of synthetic opioids and to prevent drug related deaths. The Government has long supported expanded provision of naloxone, with guidance and funding, and this has contributed to a significant growth in the amount of naloxone available in the community to reverse opioid overdoses.
In England, take-home naloxone supply is recorded by the National Drug Treatment Monitoring System, which drug and alcohol treatment services complete. It only records supply of take-home naloxone to people in registered treatment and does not record other people who may also be supplied with naloxone, like friends or family of people in treatment. Local authorities may also distribute naloxone via other routes besides substance misuse services.
We have recently published statistics on the distribution of naloxone to those in registered treatment from 2024 to 2025. The statistics can be found in the data tables in Table 1.7: naloxone distribution and use to reverse overdose, namely in Table 1.7a: naloxone issued, at the following link:
This is the first time that figures on the distribution of naloxone have been published and, therefore, trends in its distribution over time cannot yet be assessed. We intend to continue publishing statistics on naloxone distribution each year.
The Department launched a public consultation in December 2025 on further legislative options to expand access to take-home and emergency use naloxone. As part of this consultation, we are proposing specific data reporting requirements to enable more consistent reporting across the United Kingdom on the supply of take-home naloxone. The consultation closes on the 9 March 2026.